Clinical Trials Directory

Trials / Unknown

UnknownNCT01083394

Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery

Randomized Trial of Paclitaxel Eluting Balloon or Conventional Balloon for Treatment of In-Stent Restenosis of the Superficial Femoral Artery in Patients With Symptomatic Peripheral Artery Disease (ISAR-PEBIS)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to perform a randomized, controlled trial to compare percutaneous transluminal angioplasty using paclitaxel eluting balloon (PEB) or using a conventional balloon for treatment of superficial femoral artery in-stent restenosis.

Detailed description

The superficial femoral artery is a common place for arteriosclerosis in patients symptomatic for lower extremity vascular disease. Advances in percutaneous transluminal angioplasty (PTA) and stenting have provided new options for the treatment of the disease in this arterial segment. Restenosis after PTA occurs in 40-60% within one year. A novel attempt to reduce restenosis is the use of paclitaxel eluting balloons (PEB). First clinical studies suggest that the use of PEBs during percutaneous treatment of femoropopliteal disease is associated with significant reductions in late lumen loss and target-lesion revascularization. There is no randomized comparison of these treatments in patients with in stent restenosis of the superficial femoral artery. Thus, the aim of this study was to compare the efficacy of PTA with conventional balloon or PEB for in stent restenosis in the SFA in terms of reduction of diameter stenosis at follow-up angiogram.

Conditions

Interventions

TypeNameDescription
DEVICEPTAPTA using a conventional balloon
DEVICEPTA with PEBPTA using a paclitaxel eluting balloon
PROCEDUREPercutaneous Transluminal Angioplasty (PTA)Percutaneous transluminal angioplasty with conventional balloon or paclitaxel-eluting balloon

Timeline

Start date
2010-03-01
Primary completion
2014-12-01
Completion
2015-12-01
First posted
2010-03-09
Last updated
2014-03-10

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01083394. Inclusion in this directory is not an endorsement.